1-3 of 3
Sharon Love
Close
Sort by
Journal Articles

Post Induction Minimal Residual Disease Levels Identifies a Group of High Risk Relapsed Childhood Acute Lymphoblastic Leukemia (rALL) with a Favorable Outcome Independent of Induction Therapy

Catriona Anne Parker, PhD, Marie Reeves, MSc, Sharon Love, MSc, Jeremy Hancock, PhD, Peter M Hoogerbrugge, MD PhD, Rosemary Sutton, Tom Revesz, MD, Vaskar Saha, PhD FRCP, FRCPath
Journal: Blood
Blood (2015) 126 (23): 1294.
https://doi.org/10.1182/blood.V126.23.1294.1294
Published: 2015
Journal Articles

Mitoxantrone Improves the Outcome of Children with Central Nervous System (CNS) Involvement at First Relapse of Acute Lymphoblastic Leukemia (ALL)-Results of the International ALLR3 Study

Ashish Narayan Masurekar, Catriona Anne Parker, BSc, MSc, PhD, Satarupa Choudhuri, Carly Leighton, Jeremy Hancock, Rosemary Sutton, Anthony V. Moorman, PhD, Phil Ancliff, Mary Morgan, MD, Nicholas Goulden, Nina Green, Tamas Revesz, MD, PhD, FRACP, Peter Hoogerbrugge, MD, PhD, Philip Darbyshire, Sharon Love, Vaskar Saha
Journal: Blood
Blood (2010) 116 (21): 3303.
https://doi.org/10.1182/blood.V116.21.3303.3303
Published: 2010
Journal Articles

Mitoxantrone, Not Idarubicin, Significantly Improves the Outcome of Children with Relapsed ALL – Result of the International, Randomised ALLR3 Study.

Catriona Parker, Rachel Waters, Carly Leighton, Jeremy Hancock, Anthony Moorman, Mary Morgan, Philip Ancliff, Nicholas Goulden, Rosemary Sutton, Tamas Revesz, Philip Darbyshire, Sharon Love, Vaskar Saha
Journal: Blood
Blood (2009) 114 (22): 3390.
https://doi.org/10.1182/blood.V114.22.3390.3390
Published: 2009